Zimmer Financial Statements From 2010 to 2026

ZBH Stock  USD 94.75  2.10  2.27%   
Zimmer Biomet's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Zimmer Biomet's valuation are provided below:
Gross Profit
5.7 B
Profit Margin
0.1005
Market Capitalization
18.4 B
Enterprise Value Revenue
3.0783
Revenue
B
We have found one hundred twenty available fundamental gauges for Zimmer Biomet Holdings, which can be analyzed and compared to other ratios and to its peers. Traders should compare all of Zimmer Biomet Holdings prevalent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.

Zimmer Biomet Total Revenue

5.05 Billion

Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 B, Interest Expense of 145.4 M or Selling General Administrative of 2.1 B, as well as many indicators such as Price To Sales Ratio of 4.48, Dividend Yield of 0.0153 or PTB Ratio of 1.88. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Build AI portfolio with Zimmer Stock
Check out the analysis of Zimmer Biomet Correlation against competitors.

Zimmer Biomet Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding164.9 M183.5 M194 M
Pretty Stable
Total Assets14.1 B24.6 B18.6 B
Slightly volatile
Other Current Liabilities893.5 M1.6 B1.1 B
Slightly volatile
Total Current Liabilities1.6 B2.8 B2.1 B
Slightly volatile
Total Stockholder Equity7.7 B14.3 B9.6 B
Slightly volatile
Property Plant And Equipment Net1.4 B2.4 B1.7 B
Slightly volatile
Accounts Payable229.3 M223.8 M266.5 M
Slightly volatile
Non Current Assets Total10.6 B19.2 B14.3 B
Slightly volatile
Non Currrent Assets Other605.5 M1.2 B847.7 M
Slightly volatile
Net ReceivablesB1.7 B1.2 B
Slightly volatile
Liabilities And Stockholders Equity14.1 B24.6 B18.6 B
Slightly volatile
Non Current Liabilities Total4.8 B7.4 BB
Slightly volatile
Inventory1.4 B2.6 B1.8 B
Slightly volatile
Other Current Assets386.8 M494.5 M439.3 M
Slightly volatile
Total Liabilities6.4 B10.2 BB
Slightly volatile
Property Plant And Equipment Gross8.1 B7.7 B3.5 B
Slightly volatile
Total Current Assets3.5 B5.4 B4.3 B
Slightly volatile
Other Liabilities1.2 B1.3 B1.6 B
Pretty Stable
Other Assets516.1 MB675.3 M
Slightly volatile
Property Plant Equipment1.5 B2.6 B1.8 B
Slightly volatile
Short and Long Term Debt Total4.9 B7.1 B6.7 B
Pretty Stable
Net Debt3.8 B6.5 B5.3 B
Slightly volatile
Retained EarningsB12.8 B8.7 B
Slightly volatile
Cash590.7 M604.3 M664.6 M
Slightly volatile
Long Term Debt4.1 B6.1 B5.4 B
Slightly volatile
Cash And Short Term Investments726.5 M604.3 M827.4 M
Slightly volatile
Common Stock Total Equity2.9 M3.6 M2.9 M
Slightly volatile
Short Term Debt1.3 B992.5 M1.3 B
Very volatile
Common StockM3.7 M2.9 M
Slightly volatile
Good Will6.3 B10.3 B7.3 B
Slightly volatile
Intangible AssetsB5.3 B4.9 B
Slightly volatile
Retained Earnings Total Equity9.1 B11 B8.8 B
Slightly volatile
Capital Surpluse7.9 B11.5 B7.6 B
Slightly volatile
Non Current Liabilities OtherB855.7 M943.3 M
Slightly volatile
Long Term Debt Total6.3 B6.1 B5.6 B
Slightly volatile
Long Term Investments73.1 M69.6 M39.9 M
Slightly volatile
Short and Long Term Debt1.4 B776.7 M1.3 B
Very volatile
Cash And Equivalents437 M472.9 M566.6 M
Slightly volatile
Net Invested Capital13.3 B16.8 B18.6 B
Slightly volatile
Net Working CapitalB2.6 B1.8 B
Slightly volatile
Capital Stock3.4 M3.7 M3.2 M
Slightly volatile

Zimmer Biomet Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.2 B1.1 B788.4 M
Slightly volatile
Selling General Administrative2.1 B3.4 B2.6 B
Slightly volatile
Total Revenue5.1 B8.8 B6.2 B
Slightly volatile
Gross Profit3.7 B6.3 B4.4 B
Slightly volatile
Other Operating Expenses4.2 B7.4 B5.3 B
Slightly volatile
Operating Income837.3 M1.5 B831.4 M
Slightly volatile
EBIT838.7 M1.4 B805 M
Pretty Stable
Research Development265.4 M503 M327.7 M
Slightly volatile
EBITDA1.4 B2.6 B1.6 B
Slightly volatile
Cost Of Revenue1.4 B2.5 B1.8 B
Slightly volatile
Total Operating Expenses2.8 B4.8 B3.6 B
Slightly volatile
Selling And Marketing Expenses180.3 M304.8 M244.5 M
Slightly volatile
Non Recurring410.1 M336.7 M355.3 M
Pretty Stable
Interest Income164.9 M250.7 M185.7 M
Pretty Stable
Reconciled Depreciation807.1 M896.7 MB
Slightly volatile

Zimmer Biomet Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow924.4 M1.3 B1.1 B
Slightly volatile
Begin Period Cash Flow596.4 M478.2 M703.1 M
Slightly volatile
Depreciation1.2 B1.1 B796.3 M
Slightly volatile
Capital Expenditures430.8 M410.3 M212.9 M
Slightly volatile
Total Cash From Operating Activities1.1 B1.7 B1.3 B
Slightly volatile
End Period Cash Flow595.4 M604.3 M701.7 M
Slightly volatile
Dividends Paid200.6 M225.4 M207.4 M
Pretty Stable
Stock Based Compensation77 M116.2 M73.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.483.213.5385
Very volatile
Dividend Yield0.01530.01050.0138
Slightly volatile
PTB Ratio1.881.982.8155
Slightly volatile
Days Sales Outstanding55.7363.3571.0135
Slightly volatile
Book Value Per Share58.0555.2948.8104
Slightly volatile
Free Cash Flow Yield0.04110.04790.0554
Slightly volatile
Operating Cash Flow Per Share4.06.646.3207
Slightly volatile
Stock Based Compensation To Revenue0.01310.01510.0116
Pretty Stable
Capex To Depreciation0.790.410.334
Very volatile
PB Ratio1.881.982.8155
Slightly volatile
EV To Sales4.914.064.2482
Pretty Stable
Free Cash Flow Per Share3.315.065.3545
Pretty Stable
ROIC0.0620.06530.0771
Slightly volatile
Inventory Turnover1.281.131.0717
Slightly volatile
Days Of Inventory On Hand266335354
Slightly volatile
Payables Turnover10.6410.137.057
Slightly volatile
Sales General And Administrative To Revenue0.340.380.4137
Slightly volatile
Research And Ddevelopement To Revenue0.04180.05130.0508
Slightly volatile
Capex To Revenue0.04550.05340.0318
Slightly volatile
Cash Per Share2.752.334.319
Slightly volatile
POCF Ratio20.6316.4517.0697
Pretty Stable
Interest Coverage8.216.787.4612
Slightly volatile
Capex To Operating Cash Flow0.20.270.1537
Slightly volatile
PFCF Ratio25.6921.5920.3038
Slightly volatile
Days Payables Outstanding69.1237.2859.6832
Slightly volatile
EV To Operating Cash Flow22.9420.8121.0605
Pretty Stable
EV To Free Cash Flow28.6327.3125.3009
Pretty Stable
Intangibles To Total Assets0.450.570.5753
Slightly volatile
Net Debt To EBITDA1.92.273.4472
Pretty Stable
Current Ratio2.832.192.5154
Slightly volatile
Receivables Turnover5.855.965.1792
Slightly volatile
Graham Number35.6670.5658.5869
Slightly volatile
Shareholders Equity Per Share58.0155.2548.6586
Slightly volatile
Debt To Equity0.660.570.8391
Slightly volatile
Capex Per Share1.661.581.0218
Slightly volatile
Revenue Per Share18.1234.0330.3752
Slightly volatile
Interest Debt Per Share16.2428.4629.915
Slightly volatile
Debt To Assets0.180.260.2971
Pretty Stable
Enterprise Value Over EBITDA13.4210.8517.4957
Very volatile
Short Term Coverage Ratios1.92.0116
Pretty Stable
Operating Cycle321398425
Slightly volatile
Price Book Value Ratio1.881.982.8155
Slightly volatile
Days Of Payables Outstanding69.1237.2859.6832
Slightly volatile
Price To Operating Cash Flows Ratio20.6316.4517.0697
Pretty Stable
Price To Free Cash Flows Ratio25.6921.5920.3038
Slightly volatile
Operating Profit Margin0.220.190.1517
Pretty Stable
Company Equity Multiplier2.271.971.9295
Pretty Stable
Long Term Debt To Capitalization0.220.270.347
Slightly volatile
Total Debt To Capitalization0.230.30.372
Slightly volatile
Return On Capital Employed0.07430.07820.0947
Slightly volatile
Debt Equity Ratio0.660.570.8391
Slightly volatile
Ebit Per Revenue0.220.190.1517
Pretty Stable
Quick Ratio1.771.141.5596
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.213.124.0644
Slightly volatile
Net Income Per E B T0.740.781.0645
Very volatile
Cash Ratio0.230.250.4249
Slightly volatile
Cash Conversion Cycle271369367
Slightly volatile
Operating Cash Flow Sales Ratio0.250.220.2144
Pretty Stable
Days Of Inventory Outstanding266335354
Slightly volatile
Days Of Sales Outstanding55.7363.3571.0135
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.660.690.8352
Slightly volatile
Cash Flow Coverage Ratios0.260.280.3241
Slightly volatile
Price To Book Ratio1.881.982.8155
Slightly volatile
Fixed Asset Turnover4.914.314.0157
Pretty Stable
Capital Expenditure Coverage Ratio5.653.787.6581
Slightly volatile
Price Cash Flow Ratio20.6316.4517.0697
Pretty Stable
Enterprise Value Multiple13.4210.8517.4957
Very volatile
Debt Ratio0.180.260.2971
Pretty Stable
Cash Flow To Debt Ratio0.260.280.3241
Slightly volatile
Price Sales Ratio4.483.213.5385
Very volatile
Asset Turnover0.670.410.4499
Slightly volatile
Gross Profit Margin0.80.820.7276
Slightly volatile
Price Fair Value1.881.982.8155
Slightly volatile

Zimmer Biomet Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap12.9 B14.6 B15.9 B
Slightly volatile
Enterprise Value12.8 B14.4 B15.7 B
Slightly volatile

Zimmer Fundamental Market Drivers

Forward Price Earnings10.582
Cash And Short Term Investments525.5 M

Zimmer Upcoming Events

8th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-35 M-36.7 M
Total Revenue8.8 B5.1 B
Cost Of Revenue2.5 B1.4 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.38  0.34 
Research And Ddevelopement To Revenue 0.05  0.04 
Capex To Revenue 0.05  0.05 
Revenue Per Share 34.03  18.12 
Ebit Per Revenue 0.19  0.22 

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Dividend Share
0.96
Earnings Share
4.03
Revenue Per Share
40.352
Quarterly Revenue Growth
0.097
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.